Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Clinico-Neuropathological Findings in the Oldest Old from the Georgia Centenarian Study.

Tanprasertsuk J, Johnson EJ, Johnson MA, Poon LW, Nelson PT, Davey A, Martin P, Barbey AK, Barger K, Wang XD, Scott TM.

J Alzheimers Dis. 2019;70(1):35-49. doi: 10.3233/JAD-181110.

PMID:
31177211
2.

Perforant path synaptic loss correlates with cognitive impairment and Alzheimer's disease in the oldest-old.

Robinson JL, Molina-Porcel L, Corrada MM, Raible K, Lee EB, Lee VM, Kawas CH, Trojanowski JQ.

Brain. 2014 Sep;137(Pt 9):2578-87. doi: 10.1093/brain/awu190. Epub 2014 Jul 9.

3.

Neuropathology of cognitively normal elderly.

Knopman DS, Parisi JE, Salviati A, Floriach-Robert M, Boeve BF, Ivnik RJ, Smith GE, Dickson DW, Johnson KA, Petersen LE, McDonald WC, Braak H, Petersen RC.

J Neuropathol Exp Neurol. 2003 Nov;62(11):1087-95.

PMID:
14656067
4.

Neocortical lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease.

Samuel W, Galasko D, Masliah E, Hansen LA.

J Neuropathol Exp Neurol. 1996 Jan;55(1):44-52.

PMID:
8558171
5.

Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease.

Newell KL, Hyman BT, Growdon JH, Hedley-Whyte ET.

J Neuropathol Exp Neurol. 1999 Nov;58(11):1147-55.

PMID:
10560657
6.

Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART).

Josephs KA, Murray ME, Tosakulwong N, Whitwell JL, Knopman DS, Machulda MM, Weigand SD, Boeve BF, Kantarci K, Petrucelli L, Lowe VJ, Jack CR Jr, Petersen RC, Parisi JE, Dickson DW.

Acta Neuropathol. 2017 May;133(5):705-715. doi: 10.1007/s00401-017-1681-2. Epub 2017 Feb 3.

7.

Striatal amyloid plaque density predicts Braak neurofibrillary stage and clinicopathological Alzheimer's disease: implications for amyloid imaging.

Beach TG, Sue LI, Walker DG, Sabbagh MN, Serrano G, Dugger BN, Mariner M, Yantos K, Henry-Watson J, Chiarolanza G, Hidalgo JA, Souders L.

J Alzheimers Dis. 2012;28(4):869-76. doi: 10.3233/JAD-2011-111340.

8.

Capillary cerebral amyloid angiopathy in Alzheimer's disease: association with allocortical/hippocampal microinfarcts and cognitive decline.

Hecht M, Krämer LM, von Arnim CAF, Otto M, Thal DR.

Acta Neuropathol. 2018 May;135(5):681-694. doi: 10.1007/s00401-018-1834-y. Epub 2018 Mar 24.

PMID:
29574591
9.

Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons.

Boyle PA, Yu L, Nag S, Leurgans S, Wilson RS, Bennett DA, Schneider JA.

Neurology. 2015 Dec 1;85(22):1930-6. doi: 10.1212/WNL.0000000000002175. Epub 2015 Nov 4.

10.

Cerebral Amyloid Angiopathy and Neuritic Plaque Pathology Correlate with Cognitive Decline in Elderly Non-Demented Individuals.

Malek-Ahmadi M, Chen K, Perez SE, Mufson EJ.

J Alzheimers Dis. 2019;67(1):411-422. doi: 10.3233/JAD-180765.

PMID:
30594928
11.

Neuropathology of Alzheimer's disease: a critical update.

Jellinger KA, Bancher C.

J Neural Transm Suppl. 1998;54:77-95. Review.

PMID:
9850917
12.
13.

Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.

Berg L, McKeel DW Jr, Miller JP, Storandt M, Rubin EH, Morris JC, Baty J, Coats M, Norton J, Goate AM, Price JL, Gearing M, Mirra SS, Saunders AM.

Arch Neurol. 1998 Mar;55(3):326-35.

PMID:
9520006
14.

Prediction models for dementia and neuropathology in the oldest old: the Vantaa 85+ cohort study.

Hall A, Pekkala T, Polvikoski T, van Gils M, Kivipelto M, Lötjönen J, Mattila J, Kero M, Myllykangas L, Mäkelä M, Oinas M, Paetau A, Soininen H, Tanskanen M, Solomon A.

Alzheimers Res Ther. 2019 Jan 22;11(1):11. doi: 10.1186/s13195-018-0450-3.

15.

Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.

Irwin DJ, Grossman M, Weintraub D, Hurtig HI, Duda JE, Xie SX, Lee EB, Van Deerlin VM, Lopez OL, Kofler JK, Nelson PT, Jicha GA, Woltjer R, Quinn JF, Kaye J, Leverenz JB, Tsuang D, Longfellow K, Yearout D, Kukull W, Keene CD, Montine TJ, Zabetian CP, Trojanowski JQ.

Lancet Neurol. 2017 Jan;16(1):55-65. doi: 10.1016/S1474-4422(16)30291-5.

16.

Neocortical and hippocampal amyloid-β and tau measures associate with dementia in the oldest-old.

Robinson JL, Geser F, Corrada MM, Berlau DJ, Arnold SE, Lee VM, Kawas CH, Trojanowski JQ.

Brain. 2011 Dec;134(Pt 12):3708-15. doi: 10.1093/brain/awr308. Epub 2011 Nov 26.

17.

Neuropathological diagnostic criteria for Alzheimer's disease.

Murayama S, Saito Y.

Neuropathology. 2004 Sep;24(3):254-60.

PMID:
15484705
18.

Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE ε4 haplotype status: a community-based cohort study.

Yang HS, Yu L, White CC, Chibnik LB, Chhatwal JP, Sperling RA, Bennett DA, Schneider JA, De Jager PL.

Lancet Neurol. 2018 Sep;17(9):773-781. doi: 10.1016/S1474-4422(18)30251-5. Epub 2018 Aug 6.

PMID:
30093249
19.

Alzheimer disease pathology and longitudinal cognitive performance in the oldest-old with no dementia.

Balasubramanian AB, Kawas CH, Peltz CB, Brookmeyer R, Corrada MM.

Neurology. 2012 Aug 28;79(9):915-21. doi: 10.1212/WNL.0b013e318266fc77. Epub 2012 Aug 15.

20.

Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.

Bennett DA, Schneider JA, Bienias JL, Evans DA, Wilson RS.

Neurology. 2005 Mar 8;64(5):834-41.

PMID:
15753419

Supplemental Content

Support Center